Public Company

Food inflation to ease next month: Montek

The Planning Commission today said food inflation will come down next month from a more than a decade"s high of around 20 per cent, as apprehensions about adverse effect of drought were easing. - Martin Feldstein: Is gold a good hedge?">Martin Feldstein: Is gold a good hedge? - "Pvt investment in Bihar not possible without tax sops" - Food inflation at 19.83% on high potato, pulses rates - 7-8% yield not dangerous: Chakrabarty - Inflation not the only policy decider: RBI - G-sec yield may touch 8% "I think this fear of negative impact of drought being reduced, there will be a softening in food price inflation in the next month," Planning Commission Deputy Chairman Montek Singh Ahluwalia told reporters on the sidelines of a FICCI function here. He further said that inflation at the moment was not caused by excess money supply but was dominantly on account of surge in food prices. While refusing to speculate on what needs to be done to curb inflation, he said, "When inflation begins to go up, one of the instruments that people use is monetary instrument." RBI is scheduled to review its monetary policy stance later this month and has dropped hints of tightening money supply. Ahluwalia, however, said that it is a complex issue as the policy makers have to deal with only one set of price rise (food). Following widespread drought and floods in various parts of the country, food inflation climbed to more than a 10-year high of 19.95 per cent in December, driven mainly by higher prices of potato, other vegetables and pulses. According to latest figures, food inflation stood at 19.83 per cent during the third week of December.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Lunch with BS: Neville Tuli
Kishore Singh / New Delhi November 3, 2009, 0:30 IST
Popular Articles
Modern furniture stores in da

Overseas investors buy Rs 994 crore of stocks
Overseas funds bought a net Rs 994 crore ($213 million) of Indian equities yesterday, taking their investments in stocks this year to Rs 77,410 crore, the nation’s market regulator said today.

Ranbaxy, Aurobindo get USFDA nod for migraine drug
Pharma majors Ranbaxy and Aurobindo Pharma today said that they have received final approval from the US Food and Drug Administration(USFDA) to manufacture and market Sumatripan Succinate.